Urinary tract infections in liver cirrhosis
https://doi.org/10.31549/2542-1174-2026-10-1-32-44
Abstract
I n t r o d u c t i o n . Bacterial infections are a common pathology in patients with liver cirrhosis (LC) among which urinary tract infections (UTIs) are widely spread. A i m . To study the incidence, features of the course, risk factors of UTIs in hospitalized patients with LC, and the disease prognosis depending on the presence of UTIs.
M a t e r i a l s a n d m e t h o d s . A prospective observational study involving 338 hospitalized patients with LC aged 30 to 84 years (median, 55,00 (45,00; 63,00) years), 189 (55,92%) men and 149 (44,08%) women was conducted. Child-Pugh class A liver cirrhosis was diagnosed in 78 (23,08%) patients, class B – in 118 (34,91%), class C – in 142 (42,01%). Bacterial infections were detected in 172 (50,89%) patients with LC. Clinical examination, clinical investigations and laboratory tests, urine culture with antimicrobial susceptibility testing using conventional microbiological methods were performed in all the patients.
R e s u l t s . In patients with LC, the incidence of UTIs was 37,87%, and the incidence of asymptomatic bacteriuria – 23,96%. UTIs were more common in women with LC (female to male ratio was 57,81% vs. 42,19%, p < 0,001), in patients with decompensated LC (p < 0,001), and in those with LC duration of less than 5 years (p = 0,016). UTIs co-existed with other infections in 45,31% of cases. In patients with LC, UTIs with systemic manifestations (79,69%), with anatomical and structural changes of the urinary tract according to imaging studies (79%), healthcare-associated infections (44,53%), catheter-associated infections (56,25%), and infections with risk factors (RFs) (94,5%), including more than one RF in 75% of cases, predominated. Among the patients with LC and UTIs 70% died within 45 months of follow-up, which was significantly higher compared to patients without UTIs – 34% (p < 0,001).
C o n c l u s i o n . The high incidence of UTIs in hospitalized patients with LC, the complicated course with the presence of RFs, systemic inflammatory response, co-infections, and the association with an unfavorable prognosis of the disease indicate the need for their timely diagnosis and medical prevention.
About the Authors
E. G. MalaevaBelarus
Ekaterina G. Malaeva – Cand. Sci. (Med.), Associate Professor, Head, Department of Internal Medicine No. 1 with courses in Endocrinology and Hematology
5, Lange str., Gomel, 246013
I. O. Stoma
Belarus
Igor O. Stoma – Dr. Sci. (Med.), Professor, Rector
Gomel
References
1. Kranz J., Bartoletti R., Bruyère F. et al. European Association of Urology Guidelines on urological infections: Summary of the 2024 Guidelines. Eur. Urol. 2024;86(1):27-41. DOI: 10.1016/j.eururo.2024.03.035.
2. EAU. Urological Infections. The Guideline. 2025. URL: https://uroweb.org/guidelines/urological-infections/chapter/the-guideline (accessed 14.01.2026).
3. Malaeva E.G. Urinary tract infections and microbiota. Health and Ecology Issues. 2021;18(3):5-14. DOI: 10.51523/2708-6011.2021-18-3-1. (In Russ.)
4. Epidemiological diagnosis of healthcare-associated infectious diseases based on standard case definitions: Recommendations. 2023. P. 52. URL: https://chbmk95.ru/wp-content/uploads/2024/03/Методические-руководства-Эпидемиологическаядиагностика.pdf (accessed 14.01.2026).
5. Kamath S.D., Kumar U., Sarkar N., Shrivastava V. Quadruple complication in a patient with liver cirrhosis: a diagnostic conundrum. Cureus. 2024;16(7):e64953. DOI: 10.7759/cureus.64953.
6. Lingiah V.A., Pyrsopoulos N.T. Bacterial infections in cirrhotic patients in a tertiary care hospital. J. Clin. Transl. Hepatol. 2021;9(1):32-39. DOI: 10.14218/JCTH.2020.00076.
7. Rodríguez-Negrete E.V., Gálvez-Martínez M., Sánchez-Reyes K. et al. Liver cirrhosis: the immunocompromised state. J. Clin. Med. 2024;13(18):5582. DOI: 10.3390/jcm13185582.
8. Tian Y.X., Wu B.Y., An Q. et al. Global prevalence, temporal trends, and associated mortality of bacterial infections in patients with liver cirrhosis: a meta-analysis. J. Clin. Transl. Hepatol. 2025;13(11):918-934. DOI: 10.14218/JCTH.2025.00260.
9. Reuken P.A., Stallmach A., Bruns T. Mortality after urinary tract infections in patients with advanced cirrhosis – Relevance of acute kidney injury and comorbidities. Liver Int. 2013;33(2):220-230. DOI: 10.1111/liv.12029.
10. Patnaik S.K., Mohanty S., Mishra D. et al. A prospective study on the clinical significance of infections in a hospital setting among the cirrhotic patients and their outcomes. Cureus. 2023;15(4):e37912. DOI: 10.7759/cureus.37912.
Review
For citations:
Malaeva E.G., Stoma I.O. Urinary tract infections in liver cirrhosis. Journal of Siberian Medical Sciences. 2026;(1):32-44. (In Russ.) https://doi.org/10.31549/2542-1174-2026-10-1-32-44
JATS XML

























